Boehringer Ingelheim Pharma GmbH & Co. KG

Industry / private company


Location: Ingelheim am Rhein, Germany (DE) DE

ISNI: 0000000121717500

ROR: https://ror.org/00q32j219

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pawsitive impact: How pet contact ameliorates adult inflammatory stress responses in individuals raised in an urban environment (2025) Langgartner D, Weimer K, Brunner-Weisser J, Winkler R, Mannes M, Huber-Lang M, Sterrett JD, et al. Journal article Ophthalmological research in Germany: suggestions by an international expert panel (2024) Ader M, Cursiefen C, Fauser S, Gliem M, Helbig H, Lagrèze W, Marshall J, et al. Journal article New Biomarkers for Renal Transporter-Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans (2024) Geßner A, König J, Wenisch P, Heinrich M, Stopfer P, Fromm M, Müller F Journal article Ophthalmologische Forschung in Deutschland: Evaluation durch ein internationales Expertengremium (2024) Ader M, Cursiefen C, Fauser S, Gliem M, Helbig H, Lagrèze W, Marshall J, et al. Journal article The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers (2024) Tian X, Esmaeili H, Minich D, Seitz F, Roessner PM, Wind S, Grempler R, et al. Journal article A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions (2023) Geßner A, Müller F, Wenisch P, Heinrich M, König J, Stopfer P, Fromm M Journal article Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, with Cytochrome P450 and P-Glycoprotein Substrates: Findings from in Vitro Analyses and an Open-Label, Single-Sequence Phase i Study (2023) Desch M, Schlecker C, Hohl K, Liesenfeld KH, Chan T, Müller F, Wunderlich G, et al. Journal article Empagliflozin in Patients with Chronic Kidney Disease. (2023) Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, et al. Journal article Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region. (2023) Lescoat A, Huscher D, Schoof N, Airo P, De Vries-Bouwstra J, Riemekasten G, Hachulla E, et al. Journal article Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis (2023) Koop K, Enderle K, Hillmann M, Ruspeckhofer L, Vieth M, Sturm G, Trajanoski Z, et al. Journal article